Lantheus Holdings Operating Cash Flow 2011-2026 | LNTH

Annual Operating Cash Flow Lantheus Holdings

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
390 M	545 M	305 M	282 M	53.9 M	16.4 M	80.4 M	61.2 M	54.8 M	49.6 M	21.8 M	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
545 M	16.4 M	169 M

Quarterly Operating Cash Flow Lantheus Holdings

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	108 M	-	-	-	127 M	-	-	-	108 M	-	176 M	-	10.3 M	-	40 M	-	9.82 M	-	15.8 M	7.25 M	9.41 M	-	58 M	31.5 M	10.5 M	-	43.9 M	19.6 M	-666 K	-	41.7 M	26.1 M	5.52 M	-	36.9 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
176 M	-666 K	44.3 M

Operating Cash Flow of other stocks in the Diagnostics research industry

Issuer	Operating Cash Flow	Price	% 24h	Market Cap	Country
Centogene N.V. CNTG	-21.7 M	-	-6.23 %	$ 30.6 M	Germany
Agilent Technologies A	1.48 B	$ 119.3	0.94 %	$ 36.3 B	USA
Burning Rock Biotech Limited BNR	-478 M	$ 21.8	-3.29 %	$ 235 M	China
Accelerate Diagnostics AXDX	-48.7 M	-	-61.36 %	$ 2.46 M	USA
Aspira Women's Health AWH	-7.03 M	-	-6.19 %	$ 10.5 M	USA
Biocept BIOC	-13.3 M	-	-13.05 %	$ 7.29 M	USA
Check-Cap Ltd. CHEK	-8 M	-	-	$ 9.42 M	Israel
Chembio Diagnostics CEMI	-12.7 M	-	0.22 %	$ 16.8 M	USA
CareDx, Inc CDNA	42 M	$ 21.91	-2.3 %	$ 1.17 B	USA
DermTech DMTK	-77 M	-	-11.32 %	$ 2.94 M	USA
Akumin AKU	65.4 M	-	-17.87 %	$ 25.9 M	Canada
Enzo Biochem ENZ	-26.3 M	-	-8.98 %	$ 14.8 K	USA
Co-Diagnostics CODX	-29.1 M	$ 1.46	-	$ 1.94 M	USA
Exact Sciences Corporation EXAS	491 M	-	-	$ 19.8 B	USA
Castle Biosciences CSTL	64.9 M	$ 24.84	1.14 %	$ 690 M	USA
Global Cord Blood Corporation CO	614 M	-	-	$ 399 M	China
Genetic Technologies Limited GENE	-5.66 M	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	-524 M	-	0.12 %	$ 80.1 M	China
Charles River Laboratories International CRL	738 M	$ 180.31	1.99 %	$ 8.94 B	USA
Danaher Corporation DHR	6.42 B	$ 195.04	0.79 %	$ 139 B	USA
Interpace Biosciences IDXG	5.83 M	$ 2.2	-	$ 9.73 M	USA
Heska Corporation HSKA	-21.8 M	-	-	$ 1.31 B	USA
HTG Molecular Diagnostics HTGM	-18.4 M	-	-20.0 %	$ 1.06 M	USA
Illumina ILMN	837 M	$ 131.97	-0.57 %	$ 21 B	USA
Medpace Holdings MEDP	713 M	$ 513.96	-0.33 %	$ 14.8 B	USA
Fulgent Genetics FLGT	21.1 M	$ 16.33	1.21 %	$ 494 M	USA
Myriad Genetics MYGN	1.8 M	$ 5.15	3.0 %	$ 477 M	USA
Guardant Health GH	-185 M	$ 86.53	0.97 %	$ 10.8 B	USA
NeoGenomics NEO	5.23 M	$ 8.28	1.47 %	$ 1.06 B	USA
QIAGEN N.V. QGEN	654 M	-	-	$ 10.6 B	Niderland
Neogen Corporation NEOG	58.2 M	$ 9.41	1.84 %	$ 2.04 B	USA
Anixa Biosciences ANIX	-7.17 M	$ 2.81	-0.71 %	$ 91.2 K	USA
Biomerica BMRA	-3.84 M	$ 2.17	-1.36 %	$ 4.98 M	USA
Motus GI Holdings MOTS	-11.2 M	-	-34.28 %	$ 263 K	Israel
ICON Public Limited Company ICLR	1.29 B	$ 116.52	0.81 %	$ 9.61 B	Irlanda
Laboratory Corporation of America Holdings LH	1.64 B	$ 268.42	0.77 %	$ 22.3 B	USA
Celcuity CELC	-153 M	$ 123.86	-1.11 %	$ 5.79 B	USA
Senseonics Holdings SENS	-59.1 M	$ 6.73	-0.59 %	$ 281 M	USA
Soleno Therapeutics SLNO	46.8 M	$ 52.67	0.18 %	$ 2.68 B	USA
Quest Diagnostics Incorporated DGX	1.89 B	$ 191.43	-0.01 %	$ 21.2 B	USA
Neuronetics STIM	-20.4 M	$ 1.46	3.93 %	$ 96.3 M	USA
ENDRA Life Sciences NDRA	-5.18 M	$ 5.14	-0.52 %	$ 4.05 M	USA
National Research Corporation NRC	26.4 M	$ 17.95	1.87 %	$ 402 M	USA
Invitae Corporation NVTA	-493 M	-	-	$ 21.2 M	USA
Natera NTRA	-432 M	$ 199.35	1.65 %	$ 19.6 B	USA